Skinvisible (SKVI) Operating Expenses (2016 - 2025)
Skinvisible (SKVI) has disclosed Operating Expenses for 16 consecutive years, with $119169.0 as the latest value for Q4 2025.
- Quarterly Operating Expenses fell 41.51% to $119169.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $516315.0 through Dec 2025, down 15.3% year-over-year, with the annual reading at $516315.0 for FY2025, 15.3% down from the prior year.
- Operating Expenses hit $119169.0 in Q4 2025 for Skinvisible, up from $111057.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $203743.0 in Q4 2024 to a low of $105315.0 in Q4 2021.
- Historically, Operating Expenses has averaged $131062.2 across 5 years, with a median of $127881.5 in 2021.
- Biggest five-year swings in Operating Expenses: soared 43.95% in 2024 and later crashed 41.51% in 2025.
- Year by year, Operating Expenses stood at $105315.0 in 2021, then rose by 16.52% to $122716.0 in 2022, then rose by 15.34% to $141538.0 in 2023, then skyrocketed by 43.95% to $203743.0 in 2024, then tumbled by 41.51% to $119169.0 in 2025.
- Business Quant data shows Operating Expenses for SKVI at $119169.0 in Q4 2025, $111057.0 in Q3 2025, and $141237.0 in Q2 2025.